MedTrace Logo

Discontinuation of Primary and Secondary Prophylaxis for Opportunistic Infections in HIV-infected Patients

NCT01392430 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2012-05-17

No results posted yet for this study

Summary

The purpose of this study is to compare the incidence of opportunistic infections between HIV-infected patients who continue and discontinue primary or secondary prophylaxis for opportunistic infections in whom receiving combination antiretroviral therapy and achieve undetectable HIV-1 RNA, but CD4 cell counts are less than 200 cells/mm3.

Conditions

  • HIV Infection

Interventions

OTHER

Discontinuation of prophylactic drugs i.e. co-trimoxazole, dapsone, fluconazole, itraconazole, azithromycin

Discontinuation of prophylaxis for opportunistic infections

Sponsors & Collaborators

  • Chiang Mai University

    lead OTHER

Principal Investigators

  • Romanee Chaiwarith, MD, MHS. · Maharaj Nakorn Chiang Mai Hospital, Department of Medicine, Chiang Mai University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01392430 on ClinicalTrials.gov